Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Concord Medical Services (NYSE:CCM) in a research report released on Monday morning. The brokerage issued a sell rating on the stock.

Concord Medical Services Stock Performance

CCM opened at $4.51 on Monday. Concord Medical Services has a twelve month low of $3.82 and a twelve month high of $26.70. The company has a 50-day moving average price of $4.81 and a 200 day moving average price of $6.12. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.46 and a current ratio of 0.47.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.